What is the significance of mosaic attenuation of lungs on computed tomography (CT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Significance of Mosaic Attenuation of Lungs on CT

Mosaic attenuation on lung CT is a significant radiological finding that indicates one of three underlying pathological processes: small airway disease, pulmonary vascular disease, or infiltrative lung disease, with hypersensitivity pneumonitis being the most specific clinical diagnosis when the characteristic "three-density pattern" is present. 1

Definition and Appearance

  • Mosaic attenuation refers to a patchwork of regions with varying lung density on inspiratory CT images, appearing as a combination of areas with low and high attenuation 1
  • This pattern creates a geographic appearance with sharply defined borders corresponding to anatomic boundaries of secondary pulmonary lobules 2
  • The term should only be used for findings on inspiratory CT images, not to be confused with air trapping which is an expiratory finding 1

Underlying Causes

1. Small Airway Disease

  • Characterized by areas of decreased attenuation and decreased vascularity due to air trapping 1
  • Common in hypersensitivity pneumonitis, which shows ill-defined centrilobular nodules (<5mm) on inspiratory images 1
  • Air trapping is confirmed on expiratory CT images, where affected areas fail to increase in density 1

2. Pulmonary Vascular Disease

  • Seen in chronic thromboembolic pulmonary hypertension (CTEPH) and other vascular disorders 1
  • Shows inhomogeneous perfusion with hyperperfused (high attenuation) and hypoperfused (low attenuation) areas 1
  • Vessels within lucent regions appear smaller than those in more opaque lung regions 3
  • Present in 74% of patients with pulmonary hypertension due to vascular disease, compared to only 5% in pulmonary hypertension due to lung disease 4

3. Infiltrative Lung Disease

  • Areas of ground-glass opacity (high attenuation) interspersed with normal lung 1
  • Vessels appear more uniform in size throughout different regions of lung attenuation 3
  • Often seen in hypersensitivity pneumonitis and other interstitial lung diseases 5

Diagnostic Significance

Hypersensitivity Pneumonitis (HP)

  • The "three-density pattern" (previously called "headcheese sign") is highly specific for fibrotic HP 1
  • This pattern shows three different lung densities: normal-appearing lung, ground-glass opacities (high attenuation), and lucent lung (decreased attenuation with decreased vascularity) 1
  • In fibrotic HP, mosaic attenuation is often described as "extensive" and "marked" 1
  • Five or more lobules of mosaic attenuation in each of three or more lobes bilaterally has high specificity for fibrotic HP and helps differentiate it from idiopathic pulmonary fibrosis 1

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

  • CT scan in CTEPH typically shows inhomogeneous perfusion with a mosaic pattern 1
  • This "ground glass" or mosaic pattern can also be seen in pulmonary venoocclusive disease, but in that condition, it's coupled with thickening of interlobular septa not usually seen in CTEPH 1

Differentiation Between Causes

  • Expiratory CT scans are crucial for differentiating between vascular and airway diseases 3

    • In airway disease: attenuation differences are accentuated on expiration due to air trapping 1
    • In vascular disease: same gradient of attenuation between areas remains on expiration 1
  • Vessel size assessment helps distinguish causes 3

    • In small airways and vascular diseases: vessels within lucent regions appear smaller 3
    • In infiltrative diseases: vessels are more uniform in size throughout different regions 3
  • Distribution patterns provide additional clues 5

    • Fibrotic HP: typically most severe in mid or mid and lower lung zones with relative basal sparing 5
    • Non-fibrotic HP: typically diffuse without central or peripheral predominance 5

Clinical Implications

  • Mosaic attenuation should prompt consideration of specific diagnoses, particularly hypersensitivity pneumonitis when the three-density pattern is present 5
  • CT findings alone are not sufficient for definitive diagnosis and must be integrated with exposure history and clinical information 5
  • Multidisciplinary discussion is recommended for definitive diagnosis, especially in cases of suspected HP 5
  • The pattern helps guide appropriate management, including antigen avoidance in HP or anticoagulation in CTEPH 1, 5

Optimal CT Technique for Evaluation

  • Non-contrast examination with volumetric acquisition using submillimetric collimation 1
  • Both inspiratory and expiratory acquisitions are essential (expiratory to evaluate air trapping) 1
  • Thin-section CT images (<1.5 mm) using a high-spatial-frequency algorithm 1
  • Recommended radiation dose of 1-3 mSv ("reduced" dose) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

CT mosaic pattern of lung attenuation: distinguishing different causes.

AJR. American journal of roentgenology, 1995

Guideline

Hypersensitivity Pneumonitis CT Patterns and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.